ECT

Published research on ECT.

DrugsMay 21, 2026

Esketamine Failed Cost-Effectiveness vs. Cheaper TRD Options at $50K/QALY

Intranasal esketamine — FDA-approved for treatment-resistant depression in 2019 — failed cost-effectiveness benchmarks against four cheaper third-line options in a 2026 Hong Kong modeling st…

Read article →

PsychiatryMay 14, 2026

Catatonia Linked to Lower Left Paracingulate Sulcus Rate (28% vs 53%)

A 2026 hospital MRI study found that the left paracingulate sulcus was present in 31 of 109 catatonia patients (28%) vs. 171 of 323 psychiatric controls without catatonia (53%), a left-hemis…

Read article →

PsychiatryApr 29, 2026

ECT: A Modern Reappraisal of Suicide, Dementia, and Mortality

Modern administrative cohorts find no dementia signal for ECT and link it to lower suicide and mortality. The supportive literature carries known biases worth flagging.

Read article →